Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
J Environ Manage ; 261: 110244, 2020 May 01.
Article in English | MEDLINE | ID: mdl-32148311

ABSTRACT

On-line performance indicators of a microalgae-bacteria consortium were screened out from different variables based on pH and dissolved oxygen on-line measurements via multivariate projection analysis, aiming at finding on-line key state indicators to easily monitor the process. To fulfil this objective, a pilot-scale high-rate pond for urban wastewater treatment was evaluated under highly variable conditions, i.e. during the start-up period. The system was started-up without seed of either bacterial or microalgal biomass. It took around 19 days to fully develop a microalgal community assimilating nutrients significantly. Slight increases in the biomass productivities in days 26-30 suggest that the minimum time for establishing a performant bacteria-microalgae consortium could be of around one month for non-inoculated systems. At this point, the process was fully functional, meeting the European discharge limits for protected areas. The results of the statistical analyses show that both the pH and the dissolved oxygen concentration represent accurately the biochemical processes taking place under the start-up of the process. Both pH and dissolved oxygen represented accurately also the performance of the high-rate algal pond, being affordable, easily-implemented, options for monitoring, control and optimization of industrial-scale processes.


Subject(s)
Microalgae , Bacteria , Biomass , Ponds , Waste Disposal, Fluid , Wastewater
2.
Bioresour Technol ; 301: 122672, 2020 Apr.
Article in English | MEDLINE | ID: mdl-31945681

ABSTRACT

The objective of this study was to evaluate the performance of an outdoor membrane-coupled high-rate algal pond equipped with industrial-scale membranes for treating urban wastewater. Decoupling biomass retention time (BRT) and hydraulic retention time (HRT) by membrane filtration resulted in improved process efficiencies, with higher biomass productivities and nutrient removal rates when operating at low HRTs. At 6 days of BRT, biomass productivity increased from 30 to 66 and to 95 g·m-3·d-1 when operating at HRTs of 6, 4 and 2.5 days, respectively. The corresponding nitrogen removal rates were 4, 8 and 11 g N·m-3·d-1 and the phosphorous removal rates were 0.5, 1.3 and 1.6 g P·m-3·d-1. The system was operated keeping moderate specific air demands (0.25 m3·m-2·h-1), resulting in reasonable operating and maintenance costs (€0.04 per m3) and energy requirements (0.29 kWh per m3). The produced water was free of pathogens and could be directly used for reusing purposes.


Subject(s)
Wastewater , Water Purification , Biomass , Nitrogen , Ponds , Waste Disposal, Fluid
3.
Front Microbiol ; 9: 2222, 2018.
Article in English | MEDLINE | ID: mdl-30337907

ABSTRACT

Microbial consortia producing specific enzymatic cocktails are present in the gut of phytophagous and xylophagous insects; they are known to be the most efficient ecosystems to degrade lignocellulose. Here, the ability of these consortia to degrade ex vivo lignocellulosic biomass in anaerobic bioreactors was characterized in term of bioprocess performances, enzymatic activities and bacterial community structure. In a preliminary screening, guts of Ergates faber (beetle), Potosia cuprea (chafer), Gromphadorrhina portentosa (cockroach), Locusta migratoria (locust), and Gryllus bimaculatus (cricket) were inoculated in anaerobic batch reactors, in presence of grounded wheat straw at neutral pH. A short duration fermentation of less than 8 days was observed and was related to a drop of pH from 7 to below 4.5, leading to an interruption of gas and metabolites production. Consistently, a maximum of 180 mgeq.COD of metabolites accumulated in the medium, which was related to a low degradation of the lignocellulosic biomass, with a maximum of 5 and 2.2% observed for chafer and locust gut consortia. The initial cell-bound and extracellular enzyme activities, i.e., xylanase and ß-endoglucanase, were similar to values observed in the literature. Wheat straw fermentation in bioreactors leads to an increase of cell-bounded enzyme activities, with an increase of 145% for cockroach xylanase activity. Bacterial community structures were insect dependent and mainly composed of Clostridia, Bacteroidia and Gammaproteobacteria. Improvement of lignocellulose biodegradation was operated in successive batch mode at pH 8 using the most interesting consortia, i.e., locust, cockroaches and chafer gut consortia. In these conditions, lignocellulose degradation increased significantly: 8.4, 10.5, and 21.0% of the initial COD were degraded for chafer, cockroaches and locusts, respectively in 15 days. Consistently, xylanase activity tripled for the three consortia, attesting the improvement of the process. Bacteroidia was the major bacterial class represented in the bacterial community for all consortia, followed by Clostridia and Gammaproteobacteria classes. This work demonstrates the possibility to maintain apart of insect gut biological activity ex vivo and shows that lignocellulose biodegradation can be improved by using a biomimetic approach. These results bring new insights for the optimization of lignocellulose degradation in bioreactors.

4.
Chemosphere ; 211: 449-455, 2018 Nov.
Article in English | MEDLINE | ID: mdl-30077939

ABSTRACT

When microalgae are exposed to contaminants, the role of associated bacteria within the phycosphere, the microenvironment surrounding algal cells, remains largely unknown. The present study investigated the importance of algae-associated bacteria on the responses of microalgae growth to metallic and organic toxicant exposure. The effects of a polluted sediment elutriate, and of metal or pesticide mixtures at environmentally relevant concentrations (<10 µg L-1) were assessed on the growth of two microalgae strains: Isochrysis galbana, a prymnesiophyte, and Thalassiosira delicatula, a centric diatom. Both cultures were maintained as axenic or bacterized under similar conditions in batch cultures. In axenic conditions, the metal mixture addition at low concentrations alleviated limitation of growth by metals for T. delicatula relative to control, but inhibited I. galbana growth at highest concentration. In similar axenic conditions, both T. delicatula and I. galbana growth were negatively inhibited by pesticide mixture at concentrations as low as 10 ng L-1. The bacterial diversities associated with the two microalgae strains were significantly different (Bray-Curtis dissimilarity greater than 0.9) but their impact on microalgae growth was similar. The presence of bacteria reduced algal growth rate by ca. 50% compared to axenic cultures, whereas no significant effect of sediment elutriate, metal or pesticide mixtures was noticed on non-axenic algal growth rates. These results show that bacteria may have a negative effect on algal growth but can reduce pesticide toxicity or metal availability to algae.


Subject(s)
Bacteria/pathogenicity , Geologic Sediments/chemistry , Microalgae/drug effects
5.
Curr Opin Biotechnol ; 33: 279-86, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25845483

ABSTRACT

Open processes for microalgae mass cultivation and/or wastewater treatment present an air-water interface. Similarly to other open air-aquatic environments, they are subject to contamination, but as such, they also represent a source of bioaerosols. Indeed, meteorological, physico-chemical and biological factors cause aerial dispersion of the planktonic community. Operating conditions like liquid mixing or gas injection tend to both enhance microbial activity, as well as intensify aerosolization. Bacteria, virus particles, fungi and protozoa, in addition to microalgae, are all transient or permanent members of the planktonic community and can thus be emitted as aerosols. If they should remain viable, subsequent deposition on various habitats could instigate their colonization of other environments and the potential expression of their ecological function.


Subject(s)
Aerosols/metabolism , Microalgae/metabolism , Aerosols/chemistry , Animals , Environment , Humans , Microalgae/chemistry , Water/chemistry , Water/metabolism , Water Microbiology
6.
PLoS One ; 9(11): e112182, 2014.
Article in English | MEDLINE | ID: mdl-25379901

ABSTRACT

We propose using the surface of pine trees needles to biomonitor the bioaerosol emissions at a composting plant. Measurements were based on 16S rRNA gene copy numbers of Saccharopolyspora rectivirgula, a bioindicator of composting plant emissions. A sampling plan was established based on 29 samples around the emission source. The abundance of 16S rRNA gene copies of S. rectivirgula per gram of Pinus halepensis needles varied from 104 to 102 as a function of the distance. The signal reached the background level at distances around the composting plant ranging from 2 km to more than 5.4 km, depending on the local topography and average wind directions. From these values, the impacted area around the source of bioaerosols was mapped.


Subject(s)
Air Microbiology , Environmental Monitoring/methods , Pinus/microbiology , Aerosols , Gene Dosage , Plant Leaves/microbiology , RNA, Ribosomal, 16S/genetics , Saccharopolyspora/genetics , Saccharopolyspora/isolation & purification , Time Factors
7.
PLoS One ; 7(9): e45906, 2012.
Article in English | MEDLINE | ID: mdl-23029306

ABSTRACT

The search for new antimalarial chemotherapy has become increasingly urgent due to parasite resistance to current drugs. Ellagic acid (EA) is a polyphenol, recently found in various plant products, that has effective antimalarial activity in vitro and in vivo without toxicity. To further understand the antimalarial mechanism of action of EA in vitro, we evaluated the effects of EA, ascorbic acid and N-acetyl-L-cysteine (NAC), alone and/or in combination on the production of reactive oxygen species (ROS) during the trophozoite and schizonte stages of the erythrocytic cycle of P. falciparum. The parasitized erythrocytes were pre-labelled with DCFDA (dichlorofluorescein diacetate). We showed that NAC had no effect on ROS production, contrary to ascorbic acid and EA, which considerably reduced ROS production. Surprisingly, EA reduced the production of the ROS with concentrations (6.6×10(-9) - 6.6×10(-6) M) ten-fold lower than ascorbic acid (113×10(-6) M). Additionally, the in vitro drug sensitivity of EA with antioxidants showed that antiplasmodial activity is independent of the ROS production inside parasites, which was confirmed by the additive activity of EA and desferrioxamine. Finally, EA could act by reducing the glutathione content inside the Plasmodium parasite. This was consolidated by the decrease in the antiplasmodial efficacy of EA in the murine model Plasmodium yoelii- high GSH strain, known for its high glutathione content. Given its low toxicity and now known mechanism of action, EA appears as a promising antiplasmodial compound.


Subject(s)
Antimalarials/pharmacology , Antioxidants/pharmacology , Ellagic Acid/pharmacology , Glutathione/physiology , Plasmodium falciparum/drug effects , Acetylcysteine/pharmacology , Animals , Antioxidants/metabolism , Antioxidants/physiology , Ascorbic Acid/pharmacology , Buthionine Sulfoximine/pharmacology , Cells, Cultured , Deferoxamine/pharmacology , Drug Synergism , Enzyme Inhibitors/pharmacology , Erythrocytes/drug effects , Erythrocytes/metabolism , Erythrocytes/parasitology , Glutathione/metabolism , Glutathione/pharmacology , Humans , Inhibitory Concentration 50 , Mice , Oxidation-Reduction , Plasmodium falciparum/growth & development , Plasmodium falciparum/metabolism , Plasmodium yoelii/drug effects , Reactive Oxygen Species , Siderophores/pharmacology
8.
PLoS One ; 5(9): e12828, 2010 Sep 20.
Article in English | MEDLINE | ID: mdl-20877467

ABSTRACT

Obesity is associated with a chronic low-grade inflammation that predisposes to insulin resistance and the development of type 2 diabetes. In this metabolic context, gastrointestinal (GI) candidiasis is common. We recently demonstrated that the PPARγ ligand rosiglitazone promotes the clearance of Candida albicans through the activation of alternative M2 macrophage polarization. Here, we evaluated the impact of high fat diet (HFD)-induced obesity and the effect of rosiglitazone (PPARγ ligand) or WY14643 (PPARα ligand) both on the phenotypic M1/M2 polarization of peritoneal and cecal tissue macrophages and on the outcome of GI candidiasis. We demonstrated that the peritoneal macrophages and the cell types present in the cecal tissue from HF fed mice present a M2b polarization (TNF-α(high), IL-10(high), MR, Dectin-1). Interestingly, rosiglitazone induces a phenotypic M2b-to-M2a (TNF-α(low), IL-10(low), MR(high), Dectin-1(high)) switch of peritoneal macrophages and of the cells present in the cecal tissue. The incapacity of WY14643 to switch this polarization toward M2a state, strongly suggests the specific involvement of PPARγ in this mechanism. We showed that in insulin resistant mice, M2b polarization of macrophages present on the site of infection is associated with an increased susceptibility to GI candidiasis, whereas M2a polarization after rosiglitazone treatment favours the GI fungal elimination independently of reduced blood glucose. In conclusion, our data demonstrate a dual benefit of PPARγ ligands because they promote mucosal defence mechanisms against GI candidiasis through M2a macrophage polarization while regulating blood glucose level.


Subject(s)
Candidiasis/immunology , Diabetes Mellitus, Type 2/drug therapy , Diabetes Mellitus, Type 2/immunology , Dietary Fats/metabolism , Intestines/immunology , Macrophages/immunology , PPAR gamma/agonists , Thiazolidinediones/administration & dosage , Animals , Candida albicans/immunology , Candida albicans/physiology , Candidiasis/microbiology , Diabetes Mellitus, Type 2/metabolism , Diabetes Mellitus, Type 2/microbiology , Dietary Fats/immunology , Humans , Intestines/microbiology , Macrophage Activation/drug effects , Macrophages/drug effects , Male , Mice , Mice, Inbred C57BL , PPAR gamma/immunology , Rosiglitazone
9.
PLoS Pathog ; 6(1): e1000714, 2010 Jan.
Article in English | MEDLINE | ID: mdl-20062524

ABSTRACT

We recently showed that IL-13 or peroxisome proliferator activated receptor gamma (PPARgamma) ligands attenuate Candida albicans colonization of the gastrointestinal tract. Here, using a macrophage-specific Dectin-1 deficient mice model, we demonstrate that Dectin-1 is essential to control fungal gastrointestinal infection by PPARgamma ligands. We also show that the phagocytosis of yeast and the release of reactive oxygen intermediates in response to Candida albicans challenge are impaired in macrophages from Dectin-1 deficient mice treated with PPARgamma ligands or IL-13. Although the Mannose Receptor is not sufficient to trigger antifungal functions during the alternative activation of macrophages, our data establish the involvement of the Mannose Receptor in the initial recognition of non-opsonized Candida albicans by macrophages. We also demonstrate for the first time that the modulation of Dectin-1 expression by IL-13 involves the PPARgamma signaling pathway. These findings are consistent with a crucial role for PPARgamma in the alternative activation of macrophages by Th2 cytokines. Altogether these data suggest that PPARgamma ligands may be of therapeutic value in esophageal and gastrointestinal candidiasis in patients severely immunocompromised or with metabolic diseases in whom the prevalence of candidiasis is considerable.


Subject(s)
Candidiasis/immunology , Macrophages/metabolism , Membrane Proteins/metabolism , Nerve Tissue Proteins/metabolism , PPAR gamma/metabolism , Signal Transduction/immunology , Animals , Candida albicans/immunology , Candidiasis/metabolism , Cell Separation , Flow Cytometry , Interleukin-13/immunology , Interleukin-13/metabolism , Lectins, C-Type/immunology , Lectins, C-Type/metabolism , Macrophage Activation/immunology , Macrophages/immunology , Mannose Receptor , Mannose-Binding Lectins/immunology , Mannose-Binding Lectins/metabolism , Membrane Proteins/immunology , Mice , Mice, Knockout , Nerve Tissue Proteins/immunology , PPAR gamma/immunology , Phagocytosis/immunology , Reactive Oxygen Species/immunology , Reactive Oxygen Species/metabolism , Receptors, Cell Surface/immunology , Receptors, Cell Surface/metabolism , Reverse Transcriptase Polymerase Chain Reaction
10.
J Immunol ; 180(7): 4939-47, 2008 Apr 01.
Article in English | MEDLINE | ID: mdl-18354219

ABSTRACT

We recently demonstrated that in vitro peroxisome proliferator-activated receptor-gamma (PPARgamma) activation of mouse peritoneal macrophages by IL-13 or PPARgamma ligands promotes uptake and killing of Candida albicans through mannose receptor overexpression. In this study, we demonstrate that i.p. treatment of immunocompetent and immunodeficient (RAG-2(-/-)) mice with natural and synthetic PPARgamma-specific ligands or with IL-13 decreases C. albicans colonization of the gastrointestinal (GI) tract 8 days following oral infection with the yeast. We also showed that Candida GI infection triggers macrophage recruitment in cecum mucosa. These mucosal macrophages, as well as peritoneal macrophages, overexpress the mannose receptor after IL-13 and rosiglitazone treatments. The treatments promote macrophage activation against C. albicans as suggested by the increased ability of peritoneal macrophages to phagocyte C. albicans and to produce reactive oxygen intermediates after yeast challenge. These effects on C. albicans GI infection and on macrophage activation are suppressed by treatment of mice with GW9662, a selective PPARgamma antagonist, and are reduced in PPARgamma(+/-) mice. Overall, these data demonstrate that IL-13 or PPARgamma ligands attenuate C. albicans infection of the GI tract through PPARgamma activation and hence suggest that PPARgamma ligands may be of therapeutic value in esophageal and GI candidiasis in immunocompromised patients.


Subject(s)
Candidiasis/immunology , Candidiasis/metabolism , DNA-Binding Proteins/metabolism , Gastrointestinal Diseases/metabolism , Immunologic Deficiency Syndromes/metabolism , Interleukin-13/therapeutic use , PPAR gamma/metabolism , Animals , Candida albicans/drug effects , Candida albicans/physiology , Candidiasis/drug therapy , Candidiasis/pathology , Cecum/drug effects , Cecum/metabolism , Cell Movement/drug effects , DNA-Binding Proteins/deficiency , DNA-Binding Proteins/genetics , Female , Gastrointestinal Diseases/drug therapy , Gastrointestinal Diseases/immunology , Gastrointestinal Diseases/pathology , Immunologic Deficiency Syndromes/drug therapy , Immunologic Deficiency Syndromes/immunology , Immunologic Deficiency Syndromes/pathology , Lectins, C-Type/metabolism , Ligands , Macrophages/cytology , Macrophages/drug effects , Macrophages/metabolism , Mannose Receptor , Mannose-Binding Lectins/metabolism , Mice , Mice, Knockout , PPAR gamma/antagonists & inhibitors , Receptors, Cell Surface/metabolism , Rosiglitazone , Thiazolidinediones/therapeutic use
11.
Mol Immunol ; 45(1): 235-43, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17568676

ABSTRACT

Th2 cytokines such as interleukin-13 (IL-13) have both, stimulatory and inhibitory effects on effector functions of macrophages. Reactive nitrogen species are classically induced in Th1 cytokines and/or lipopolysaccharides (LPS) activated macrophages and this response is inhibited by IL-13. In contrast, IL-13 primes macrophages to produce NO in response to LPS when IL-13 treatment happens prior to LPS exposure. This mechanism occurs through a complex signalling pathway, which involves the scavenger receptor CD36, the LPS receptor CD14 and the nuclear receptor PPARgamma. The enhancement of NO production is the consequence of iNOS induction at mRNA and protein levels. The increase of the NO production induced by LPS in IL-13 pre-treated macrophages is found to potentiate the inhibition of Toxoplasma gondii intracellular replication. These results reveal a novel IL-13 signalling pathway that primes the antimicrobial activity of macrophages induced by LPS caused by overexpression of the iNOS-NO axis.


Subject(s)
Interleukin-13/pharmacology , Lipopolysaccharides/pharmacology , Macrophages, Peritoneal/drug effects , Macrophages, Peritoneal/enzymology , Nitric Oxide Synthase Type II/biosynthesis , Animals , Anti-Infective Agents , CD36 Antigens/metabolism , Cell Proliferation/drug effects , Enzyme Induction/drug effects , Female , Gene Expression Regulation, Enzymologic/drug effects , Lipopolysaccharide Receptors/metabolism , Macrophage Activation/drug effects , Macrophages, Peritoneal/cytology , Macrophages, Peritoneal/parasitology , Mice , Nitric Oxide/biosynthesis , Nitric Oxide Synthase Type II/genetics , PPAR gamma/agonists , RNA, Messenger/genetics , RNA, Messenger/metabolism , Toxoplasma/cytology , Toxoplasma/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...